Medication Safety in Older Adults: Evidence-Based Review for Healthcare Professionals

Abstract

Medication safety in older adults is a critical aspect of geriatric medicine, given the heightened vulnerability of this population to adverse drug events (ADEs), polypharmacy, and pharmacokinetic and pharmacodynamic changes associated with aging. This review synthesizes contemporary evidence, clinical guidelines, and expert recommendations to provide a comprehensive overview of medication safety challenges, risk factors, diagnostic considerations, and management strategies, emphasizing both foundational and emerging approaches for optimizing pharmacotherapy in older adults.

Introduction

As populations age worldwide, the proportion of older adults requiring pharmacological intervention continues to increase. Older adults often have multiple chronic conditions necessitating complex medication regimens, which, combined with age-related physiological changes, places them at increased risk for medication-related harm. This article aims to elucidate the multifaceted issues underlying medication safety in older adults, drawing upon current research, clinical guidelines, and expert opinion to inform safe and effective prescribing practices.

Epidemiology / Disease Burden

Polypharmacy is prevalent among older adults, with estimates suggesting that up to 40% of individuals over the age of 65 take at least five medications concurrently. Adverse drug events account for nearly 10% of hospital admissions in this demographic, and medication errors are a significant contributor to morbidity and mortality. The World Health Organization identifies medication safety in older adults as a global patient safety challenge, citing the growing burden of chronic disease, multimorbidity, and transitions of care as key contributing factors. In the United States, the annual cost of medication-related problems in older adults is estimated to exceed $200 billion.

Pathophysiology

Aging induces complex changes in drug absorption, distribution, metabolism, and excretion. Reduced gastric acidity and slower gastrointestinal transit can alter absorption profiles. Decreased total body water, increased body fat, and reduced lean body mass impact the volume of distribution for hydrophilic and lipophilic drugs differently. Hepatic metabolism is often diminished due to decreased liver mass and blood flow, affecting first-pass and phase I reactions. Renal clearance declines with age, even in the absence of overt renal disease, leading to accumulation of renally excreted drugs and metabolites. These pharmacokinetic alterations are compounded by increased pharmacodynamic sensitivity, particularly for central nervous system agents, antihypertensives, and anticoagulants, increasing the risk of toxicity and adverse reactions.

Risk Factors

Key risk factors for medication-related harm in older adults include polypharmacy, inappropriate prescribing (e.g., use of potentially inappropriate medications as defined by the Beers Criteria), cognitive impairment, impaired renal or hepatic function, frailty, low health literacy, and multiple prescribers. The presence of drug-drug and drug-disease interactions further amplifies risk. Social determinants, such as limited access to healthcare, social support, and economic constraints, may hinder effective medication management and adherence.

Clinical Features

Clinical manifestations of medication-related problems in older adults are often nonspecific and may mimic or exacerbate underlying geriatric syndromes, such as falls, delirium, incontinence, or functional decline. Adverse drug reactions may present atypically, for example, with confusion or dizziness rather than classic symptoms. This underscores the need for vigilance and a high index of suspicion when evaluating new or worsening symptoms in older patients.

Diagnosis

Diagnosis of medication-related harm involves a thorough medication reconciliation, including prescription, over-the-counter, and herbal products. Structured tools such as the Medication Appropriateness Index, STOPP/START criteria, and Beers Criteria can aid in identifying potentially inappropriate medications. Comprehensive geriatric assessment, including cognitive and functional evaluation, is essential to contextualize pharmacotherapy and detect subtle adverse effects. Laboratory monitoring and assessment of renal and hepatic function are critical to guide dose adjustments.

Treatment & Management

Optimizing medication safety in older adults requires individualized assessment and shared decision-making. Deprescribing, or the systematic withdrawal of inappropriate or unnecessary medications, is increasingly recognized as a cornerstone of geriatric pharmacotherapy. Regular medication reviews, simplification of regimens, and use of the lowest effective doses are key strategies. Patient education, clear communication, and engagement of caregivers are crucial to ensure adherence and early detection of adverse events. Close monitoring is essential during transitions of care, a period associated with particularly high risk of medication errors.

Recent Advances / Emerging Therapies

Recent advances in medication safety include the development of electronic prescribing systems with built-in clinical decision support, which can alert prescribers to potential drug-drug interactions, dosing errors, and inappropriate medications. Pharmacogenomic testing is emerging as a tool to personalize therapy and reduce adverse reactions in select cases. The use of multidisciplinary teams, including pharmacists, has shown to reduce medication-related hospitalizations and improve outcomes in older adults. Mobile health applications and telemedicine are being leveraged to support medication tracking and adherence, especially in community-dwelling seniors.

Guideline Recommendations

Major guidelines, including those from the American Geriatrics Society and European Society for Geriatric Medicine, recommend regular medication review, avoidance of high-risk medications as per the Beers Criteria, dose adjustment based on renal and hepatic function, and patient-centered approaches to prescribing. Emphasis is placed on deprescribing where appropriate, involving patients and caregivers in decision-making, and ensuring robust communication across care settings. Multidisciplinary interventions and pharmacist-led medication reconciliation at transitions of care are strongly supported by evidence and guidelines.

Conclusion

Medication safety in older adults represents a significant and multifaceted challenge in clinical practice. A comprehensive, individualized, and evidence-based approach grounded in careful assessment, judicious prescribing, and ongoing review is essential for minimizing harm and optimizing therapeutic outcomes. Advancements in technology, multidisciplinary care models, and guideline-driven practices hold promise for improving medication safety in this vulnerable population, underscoring the need for continuous education and vigilance among healthcare professionals.